Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bacterial efflux pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23FN4O |
InChIKeyLLMXOOJGLBAXRX-ACJLOTCBSA-N |
CAS Registry2243960-05-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pseudomonas aeruginosa infection | Preclinical | United States | 26 May 2022 |





